EP0982401A3 - Arzneimittel-Ziele in Candida albicans - Google Patents

Arzneimittel-Ziele in Candida albicans Download PDF

Info

Publication number
EP0982401A3
EP0982401A3 EP98310694A EP98310694A EP0982401A3 EP 0982401 A3 EP0982401 A3 EP 0982401A3 EP 98310694 A EP98310694 A EP 98310694A EP 98310694 A EP98310694 A EP 98310694A EP 0982401 A3 EP0982401 A3 EP 0982401A3
Authority
EP
European Patent Office
Prior art keywords
candida albicans
activity
compound
growth
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98310694A
Other languages
English (en)
French (fr)
Other versions
EP0982401A2 (de
Inventor
Roland Henri Contreras
Bart Nelissen
Marianne Denise De Backer
Walter Herman Maria Louis Luyten
Jasmine Elsa Viaene
Marc George Logghe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Priority to PCT/EP1999/005991 priority Critical patent/WO2000009695A2/en
Priority to AU57354/99A priority patent/AU774719B2/en
Priority to IL14138599A priority patent/IL141385A0/xx
Priority to NZ510118A priority patent/NZ510118A/en
Priority to JP2000565130A priority patent/JP2003512007A/ja
Priority to CA002339337A priority patent/CA2339337A1/en
Priority to EP99944406A priority patent/EP1105494A2/de
Publication of EP0982401A2 publication Critical patent/EP0982401A2/de
Publication of EP0982401A3 publication Critical patent/EP0982401A3/de
Priority to IL141385A priority patent/IL141385A/en
Priority to AU2004218678A priority patent/AU2004218678A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP98310694A 1998-08-14 1998-12-23 Arzneimittel-Ziele in Candida albicans Withdrawn EP0982401A3 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002339337A CA2339337A1 (en) 1998-08-14 1999-08-16 Drug targets in candida albicans
AU57354/99A AU774719B2 (en) 1998-08-14 1999-08-16 Drug targets in candida albicans
IL14138599A IL141385A0 (en) 1998-08-14 1999-08-16 Drug targets in candida albicans
NZ510118A NZ510118A (en) 1998-08-14 1999-08-16 Nucleic acids and polypeptides from Candida albicans
JP2000565130A JP2003512007A (ja) 1998-08-14 1999-08-16 カンジダ・アルビカンス中の薬剤標的
PCT/EP1999/005991 WO2000009695A2 (en) 1998-08-14 1999-08-16 Drug targets in candida albicans
EP99944406A EP1105494A2 (de) 1998-08-14 1999-08-16 Arzneimittel-ziele in candida albicans
IL141385A IL141385A (en) 1998-08-14 2001-02-12 Drug sites in Candida albicans
AU2004218678A AU2004218678A1 (en) 1998-08-14 2004-10-08 Drug targets in candida albicans

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9817796.7A GB9817796D0 (en) 1998-08-14 1998-08-14 Drug targets in candida albicans
GB9817796 1998-08-14

Publications (2)

Publication Number Publication Date
EP0982401A2 EP0982401A2 (de) 2000-03-01
EP0982401A3 true EP0982401A3 (de) 2000-04-19

Family

ID=10837312

Family Applications (2)

Application Number Title Priority Date Filing Date
EP98310694A Withdrawn EP0982401A3 (de) 1998-08-14 1998-12-23 Arzneimittel-Ziele in Candida albicans
EP99944406A Withdrawn EP1105494A2 (de) 1998-08-14 1999-08-16 Arzneimittel-ziele in candida albicans

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP99944406A Withdrawn EP1105494A2 (de) 1998-08-14 1999-08-16 Arzneimittel-ziele in candida albicans

Country Status (8)

Country Link
EP (2) EP0982401A3 (de)
JP (1) JP2003512007A (de)
AU (2) AU774719B2 (de)
CA (1) CA2339337A1 (de)
GB (1) GB9817796D0 (de)
IL (1) IL141385A (de)
NZ (1) NZ510118A (de)
WO (1) WO2000009695A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
KR100453719B1 (ko) * 2001-10-25 2004-10-20 최원자 캔디다 알비칸스에서 유전자 조작의 효율적 연구를 위한일련의 재조합 벡터
CA2438753A1 (en) * 2003-08-28 2005-02-28 Susana Garcia-Sanchez Genes involved in biofilm formation by the pathogenic yeast candida albicans

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996036707A1 (en) * 1995-05-16 1996-11-21 Universita' Degli Studi Di Roma 'la Sapienza' CANDIDA HEAT SHOCK PROTEIN, cDNA AND USES THEREOF
WO1997036925A1 (en) * 1996-04-01 1997-10-09 Scriptgen Pharmaceuticals, Inc. Candida albicans tata-binding protein, nucleic acid and assays
WO1997037230A1 (en) * 1996-04-01 1997-10-09 Scriptgen Pharmaceuticals, Inc. Tfiib transcription factor from candida albicans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869290A (en) * 1996-11-21 1999-02-09 Smithkline Beecham Corporation Cayae1 polynucleotides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996036707A1 (en) * 1995-05-16 1996-11-21 Universita' Degli Studi Di Roma 'la Sapienza' CANDIDA HEAT SHOCK PROTEIN, cDNA AND USES THEREOF
WO1997036925A1 (en) * 1996-04-01 1997-10-09 Scriptgen Pharmaceuticals, Inc. Candida albicans tata-binding protein, nucleic acid and assays
WO1997037230A1 (en) * 1996-04-01 1997-10-09 Scriptgen Pharmaceuticals, Inc. Tfiib transcription factor from candida albicans

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DALY S ET AL: "Isolation and characterization of a gene encoding alpha-tubulin from Candida albicans", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES,GB,ELSEVIER SCIENCE PUBLISHERS, BARKING, vol. 187, no. 2, pages 151-158, XP004093273, ISSN: 0378-1119 *

Also Published As

Publication number Publication date
EP1105494A2 (de) 2001-06-13
JP2003512007A (ja) 2003-04-02
WO2000009695A2 (en) 2000-02-24
AU5735499A (en) 2000-03-06
IL141385A (en) 2007-08-19
CA2339337A1 (en) 2000-02-24
AU2004218678A1 (en) 2004-11-04
AU774719B2 (en) 2004-07-08
NZ510118A (en) 2004-05-28
WO2000009695A3 (en) 2000-06-22
EP0982401A2 (de) 2000-03-01
GB9817796D0 (en) 1998-10-14

Similar Documents

Publication Publication Date Title
Zubenko et al. Septum formation, cell division, and sporulation in mutants of yeast deficient in proteinase B.
Stargardt et al. Reversible heterogeneous reduction and oxidation of sperm whale myoglobin at a surface modified gold minigrid electrode
Doyle et al. Enzyme-linked immunoadsorbent assay with electrochemical detection of. alpha. 1-acid glycoprotein
CA2394821A1 (en) Cell arrays and the uses thereof
WO2004044178A3 (en) Methods and compositions for diagnosing dysplasia
Veenstra Electrospray ionization mass spectrometry: a promising new technique in the study of protein/DNA noncovalent complexes
WO2002000006A3 (en) Nucleic acid enzyme biosensor for ions
WO2000026408A3 (en) A system for cell-based screening
WO2001027624A3 (en) Compositions and methods for detecting protein modification and enzymatic activity
CA2109896A1 (en) Method and system for determining bioactive substances
EP1103807A3 (de) Wasserstoffgassensor
WO2000007017A3 (en) Method of high-throughput screening
WO2001011341A3 (en) A system for cell-based screening
WO1999055913A3 (en) Reduced complexity nucleic acid targets and methods of using same
AUPO128096A0 (en) Biosensors
Chambers et al. Variation in the biochemical properties of the Drosophila alcohol dehydrogenase allozymes
Zheng et al. Dual-modal biosensor for highly sensitive and selective DNA methyltransferase activity detection based on a porous organic polymer-inorganic nanocomposite (Cu2O@ FePPOPBADE) with high laccase-like activity
Duggins et al. Analysis of a hybrid zone in Fundulus majalis in a northeastern Florida ecotone
EP0982401A3 (de) Arzneimittel-Ziele in Candida albicans
WO2000046375A3 (en) Methods for producing polypeptides in fungal cells
NZ515568A (en) Cell death related drug targets in yeast and fungi
EP0155832A3 (de) Stabile Proteine, Verfahren zu deren Herstellung, dieselben kodierende Plasmide und andere DNS, diese Plasmide enthaltende Zellkulturen
WO2005028677A3 (en) Systems and methods for determining cell type composition of mixed cell populations using gene expression signatures
Lubrano et al. Amperometric alcohol electrode with extended linearity and reduced interferences
Chambers The purification and biochemical properties of alcohol dehydrogenase—“Fast (Chateau Douglas)” from Drosophila melanogaster

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RTI1 Title (correction)

Free format text: DRUG TARGETS IN CANDIDA ALBICANS

AKX Designation fees paid

Free format text: AT

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20001020

REG Reference to a national code

Ref country code: DE

Ref legal event code: 8566